Dengler T - Search Results

1

Prevalence of different gadolinium enhancement patterns in patients after heart transplantation.

Steen H, Merten C, Refle S, Klingenberg R, Dengler T, Giannitsis E, Katus HA. Steen H, et al. Among authors: dengler t. J Am Coll Cardiol. 2008 Sep 30;52(14):1160-7. doi: 10.1016/j.jacc.2008.05.059. J Am Coll Cardiol. 2008. PMID: 18804744 Free article.

2

[Return to work after heart transplantation].

Kristen AV, Katus HA, Dengler TJ. Kristen AV, et al. Versicherungsmedizin. 2010 Jun 1;62(2):67-72. Versicherungsmedizin. 2010. PMID: 20575476 German.

3

Intravenous delivery of autologous mesenchymal stem cells limits infarct size and improves left ventricular function in the infarcted porcine heart.

Krause U, Harter C, Seckinger A, Wolf D, Reinhard A, Bea F, Dengler T, Hardt S, Ho A, Katus HA, Kuecherer H, Hansen A. Krause U, et al. Among authors: dengler t. Stem Cells Dev. 2007 Feb;16(1):31-7. doi: 10.1089/scd.2006.0089. Stem Cells Dev. 2007. PMID: 17348804

4

Impact of pre-operative diabetes mellitus upon early and late survival after heart transplantation: a possible era effect.

Klingenberg R, Gleissner C, Koch A, Schnabel PA, Sack FU, Zimmermann R, Katus HA, Dengler TJ. Klingenberg R, et al. J Heart Lung Transplant. 2005 Sep;24(9):1239-46. doi: 10.1016/j.healun.2004.09.007. J Heart Lung Transplant. 2005. PMID: 16143240

5

Biomarkers after heart transplantation: nongenomic.

Dengler TJ, Gleissner CA, Klingenberg R, Sack FU, Schnabel PA, Katus HA. Dengler TJ, et al. Heart Fail Clin. 2007 Jan;3(1):69-81. doi: 10.1016/j.hfc.2007.02.010. Heart Fail Clin. 2007. PMID: 17545010

6

Serum levels of NT-proBNP as surrogate for cardiac amyloid burden: new evidence from gadolinium-enhanced cardiac magnetic resonance imaging in patients with amyloidosis.

Lehrke S, Steen H, Kristen AV, Merten C, Lossnitzer D, Dengler TJ, Katus HA, Giannitsis E. Lehrke S, et al. Amyloid. 2009 Dec;16(4):187-95. doi: 10.3109/13506120903421538. Amyloid. 2009. PMID: 19922329

7

Quantitative myocardial blush grade for the detection of cardiac allograft vasculopathy.

Korosoglou G, Riedle N, Erbacher M, Dengler TJ, Zugck C, Rottbauer W, Hardt S, Bekeredjian R, Kristen A, Giannitsis E, Osman NF, Dickhaus H, Katus HA. Korosoglou G, et al. Am Heart J. 2010 Apr;159(4):643-651.e2. doi: 10.1016/j.ahj.2009.12.023. Am Heart J. 2010. PMID: 20362724

8

Effects of vildagliptin (Galvus®) therapy in patients with type 2 diabetes mellitus after heart transplantation.

Gueler I, Mueller S, Helmschrott M, Oeing CU, Erbel C, Frankenstein L, Gleißner C, Ruhparwar A, Ehlermann P, Dengler TJ, Katus HA, Doesch AO. Gueler I, et al. Drug Des Devel Ther. 2013 Apr 8;7:297-303. doi: 10.2147/DDDT.S43092. Print 2013. Drug Des Devel Ther. 2013. PMID: 23630415 Free PMC article.

9

Reduced hemoglobin after heart transplantation is no independent risk factor for survival but is associated closely with impaired renal function.

Gleissner CA, Murat A, Schäfer S, Klingenberg R, Koch A, Remppis A, Zimmermann R, Katus HA, Dengler TJ. Gleissner CA, et al. Transplantation. 2004 Mar 15;77(5):710-7. doi: 10.1097/01.tp.0000116443.64958.88. Transplantation. 2004. PMID: 15021834

10

Determinants of B-type natriuretic peptide plasma levels in the chronic phase after heart transplantation.

Klingenberg R, Koch A, Gleissner C, Schnabel PA, Haass M, Remppis A, Katus HA, Dengler TJ. Klingenberg R, et al. Transpl Int. 2005 Feb;18(2):169-76. doi: 10.1111/j.1432-2277.2004.00010.x. Transpl Int. 2005. PMID: 15691269 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

195 results

Search Page

Filters